The significant price surge and subsequent trading halt of Regulus Therapeutics shares indicate a highly positive market reaction to potentially company-specific news or broader sector momentum. This dramatic increase is likely to attract increased investor attention and could lead to further volatility in the short term. The halt due to a circuit breaker underscores the magnitude of the price movement.